Brokerages Set The Cooper Companies, Inc. (NASDAQ:COO) Target Price at $90.77

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been given an average recommendation of “Moderate Buy” by the sixteen brokerages that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $90.7692.

Several analysts recently commented on COO shares. The Goldman Sachs Group reaffirmed a “sell” rating and set a $73.00 target price on shares of Cooper Companies in a report on Friday, January 9th. Barclays set a $98.00 target price on Cooper Companies and gave the company an “overweight” rating in a research report on Monday, January 26th. Stifel Nicolaus set a $95.00 price target on Cooper Companies and gave the stock a “buy” rating in a report on Friday, December 5th. Needham & Company LLC reduced their price target on Cooper Companies from $100.00 to $99.00 and set a “buy” rating for the company in a research note on Tuesday, February 3rd. Finally, William Blair upgraded Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III bought 10,000 shares of the firm’s stock in a transaction on Tuesday, December 16th. The shares were purchased at an average price of $80.80 per share, for a total transaction of $808,000.00. Following the transaction, the chief executive officer directly owned 236,151 shares in the company, valued at approximately $19,081,000.80. This trade represents a 4.42% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Cynthia L. Lucchese purchased 1,784 shares of the company’s stock in a transaction dated Monday, December 22nd. The stock was acquired at an average price of $84.06 per share, with a total value of $149,963.04. Following the completion of the transaction, the director owned 9,445 shares of the company’s stock, valued at $793,946.70. This represents a 23.29% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 16,014 shares of company stock valued at $1,304,416 in the last quarter. Company insiders own 1.98% of the company’s stock.

Institutional Trading of Cooper Companies

A number of institutional investors have recently modified their holdings of COO. Buckhead Capital Management LLC raised its position in shares of Cooper Companies by 14.3% during the third quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock worth $4,040,000 after acquiring an additional 7,368 shares during the last quarter. First American Bank acquired a new stake in Cooper Companies during the 3rd quarter valued at approximately $1,646,000. Rakuten Investment Management Inc. acquired a new stake in Cooper Companies during the 3rd quarter valued at approximately $11,341,000. Amundi raised its holdings in Cooper Companies by 35.5% during the 2nd quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock worth $97,225,000 after purchasing an additional 348,652 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in shares of Cooper Companies by 96.9% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock worth $212,519,000 after purchasing an additional 1,525,693 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $81.94 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The business’s 50 day moving average price is $82.00 and its two-hundred day moving average price is $75.01. The company has a market cap of $16.06 billion, a PE ratio of 43.59, a price-to-earnings-growth ratio of 2.37 and a beta of 1.03. Cooper Companies has a twelve month low of $61.78 and a twelve month high of $92.84.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, analysts predict that Cooper Companies will post 3.98 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.